mRNA vaccine and therapeutics biotech developing novel cap analogues
| Date | Round | Amount |
|---|---|---|
| Dec 2022 | Grant Polish biotech ExPLoRNA Therapeutics received over $800K in grant funding from the Bill & Melinda Gates Foundation to advance its mRNA cap-analogue technology. | $800K |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.